Literature DB >> 6892242

Inhibition of forskolin-activated adenylate cyclase by ethanol and other solvents.

R D Huang, M F Smith, W L Zahler.   

Abstract

Ethanol and a variety of solvents are known to activate basal and Gpp(NH)p- and hormone-stimulated adenylate cyclase. We report here that ethanol and other solvents inhibit the activation of adenylate cyclase by forskolin. In the presence of 10 microM forskolin, 2% ethanol gives about 20% inhibition and 5% ethanol gives 40% inhibition of enzyme activity. Analysis of ethanol inhibition at several forskolin concentrations suggests that inhibition is competitive versus forskolin. Thus the effect of ethanol is greater at low forskolin concentrations and minimal at high concentrations. In addition to ethanol, inhibition of forskolin activation was observed with acetone, n-butanol, t-butanol, dimethyl formamide, dioxane, methanol and n-propanol. Dimethyl sulfoxide was inhibitory only at high concentrations (10%). Since some solvent is needed to prepare forskolin solutions and to maintain solubility at higher concentrations, the inhibitory effects reported here are an important consideration in studies employing forskolin activation. To minimize solvent inhibition we recommend that dimethyl sulfoxide be used to prepare forskolin solutions. At concentrations of 5% and less, dimethyl sulfoxide gives little if any inhibition of forskolin activation and causes only small increases in basal activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6892242

Source DB:  PubMed          Journal:  J Cyclic Nucleotide Res        ISSN: 0095-1544


  11 in total

1.  Effects of lead on adenylate cyclase activity in rat cerebral cortex.

Authors:  A L Rodrigues; A Regner; M A Rubin; D O Souza
Journal:  Neurochem Res       Date:  1999-08       Impact factor: 3.996

2.  Herpesvirus quiescence in neuronal cells IV: virus activation induced by pituitary adenylate cyclase-activating polypeptide (PACAP) involves the protein kinase A pathway.

Authors:  R J Danaher; A D Savells-Arb; S A Black ; R J Jacob; C S Miller
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

3.  Glucagon treatment interferes with an early step of duck hepatitis B virus infection.

Authors:  M Hild; O Weber; H Schaller
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

Review 4.  Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate.

Authors:  Mikael Angehagen; Elinor Ben-Menachem; Lars Rönnbäck; Elisabeth Hansson
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

5.  The local anaesthetic benzyl alcohol attenuates the alpha 2-adrenoceptor-mediated inhibition of human platelet adenylate cyclase activity when stimulated by prostaglandin E1, but not that stimulated by forskolin.

Authors:  S Spence; M D Houslay
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

6.  Catecholamine-induced regulation in vitro and ex vivo of intralymphocyte ionized magnesium.

Authors:  P Delva; C Pastori; M Degan; G Montesi; A Lechi
Journal:  J Membr Biol       Date:  2004-06-01       Impact factor: 1.843

7.  Effect of forskolin on islet cyclic AMP, insulin secretion, blood glucose and intravenous glucose tolerance in rats.

Authors:  H P Ammon; A B Müller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000

8.  Effects of low doses of forskolin on the c-wave of the direct current electroretinogram and on the standing potential of the eye.

Authors:  S Jarkman
Journal:  Doc Ophthalmol       Date:  1987-12       Impact factor: 2.379

9.  Herpesvirus quiescence in neuronal cells. V: forskolin-responsiveness of the herpes simplex virus type 1 alpha0 promoter and contribution of the putative cAMP response element.

Authors:  Robert J Danaher; Robert J Jacob; Craig S Miller
Journal:  J Neurovirol       Date:  2003-08       Impact factor: 2.643

10.  Colonic epithelial ion transport is not affected in patients with diverticulosis.

Authors:  Philip S Osbak; Niels Bindslev; Steen S Poulsen; Nicolai Kaltoft; Maria C Tilotta; Mark B Hansen
Journal:  BMC Gastroenterol       Date:  2007-09-23       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.